MedPath

Inflammatory Stress and Periodontal Tissue Destruction

Completed
Conditions
Inflammation
Oxidative Stress
Interventions
Other: Gingival crevicular fluid (GCF) and serum samples
Registration Number
NCT06092853
Lead Sponsor
Recep Tayyip Erdogan University Training and Research Hospital
Brief Summary

Metabolic syndrome and periodontitis are diseases that lower the quality of life and their incidence rates are increasing. Since both of these diseases are associated with systemic inflammation and insulin resistance, they may be comorbid. The aim of this study was to evaluate the effect of interleukin-20 (IL-20) on periodontal destruction in individuals with metabolic syndrome while considering the relationship between metabolic syndrome and periodontitis.

This study included a total of 80 individuals who were systemically and periodontally healthy (CG, n=20), were systemically healthy and had periodontitis (PG, n=20), had metabolic syndrome and were periodontally healthy (MG, n=20), or had both metabolic syndrome and periodontitis (MPG, n=20). Gingival crevicular fluid (GCF) and serum samples were collected from all participants for biochemical analyses.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
80
Inclusion Criteria
  • all participants were required to have at least 20 teeth and be between the ages of 20 and 65 years
Exclusion Criteria
  • Smokers, patients who had used antibiotics or anti-inflammatory and antioxidant drugs in the last 6 months, patients who were pregnant or lactating, those who had cancer or autoimmune diseases, and those who had undergone any periodontal treatment in the last 6 months

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Metabolic syndrome and periodontitis (MPG)Gingival crevicular fluid (GCF) and serum samplesGingival crevicular fluid (GCF) and serum samples were collected from all participants for biochemical analyses
systemically healthy and periodontitis (PG)Gingival crevicular fluid (GCF) and serum samplesGingival crevicular fluid (GCF) and serum samples were collected from all participants for biochemical analyses
systemically and periodontally healthy (CG)Gingival crevicular fluid (GCF) and serum samplesGingival crevicular fluid (GCF) and serum samples were collected from all participants for biochemical analyses.
Metabolic syndrome and periodontally healthy (MG)Gingival crevicular fluid (GCF) and serum samplesGingival crevicular fluid (GCF) and serum samples were collected from all participants for biochemical analyses
Primary Outcome Measures
NameTimeMethod
concentration of serum parameters1 year

interleukin-20, RANKL, OPG, MMP-8, TOS, TAS values evaluated in serum

concentration of gingival crevicular fluid (GCF) parameters1 year

interleukin-20, RANKL, OPG values evaluated in GCF.

Secondary Outcome Measures
NameTimeMethod
value of periodontal clinical parameters1 year

plaque index, gingival index, bleeding on probing, Clinical attachment loss, probing pocket depth

value of patients' clinical metabolic syndrome parameters1 year

Body mass index (BMI), abdominal circumference, and HbA1c

Trial Locations

Locations (1)

Recep Tayyip Erdogan University

🇹🇷

Rize, Turkey

© Copyright 2025. All Rights Reserved by MedPath